On Tuesday, Aptose Biosciences Inc (NASDAQ: APTO) opened lower -5.70% from the last session, before settling in for the closing price of $0.20. Price fluctuations for APTO have ranged from $0.13 to $2.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 76.39% at the time writing. With a float of $56.47 million, this company’s outstanding shares have now reached $60.18 million.
The firm has a total of 35 workers. Let’s measure their productivity. In terms of profitability, gross margin is 52.33%, operating margin of -5123.32%, and the pretax margin is -5066.98%.
Aptose Biosciences Inc (APTO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Aptose Biosciences Inc is 6.17%, while institutional ownership is 5.37%. The most recent insider transaction that took place on Nov 25 ’24, was worth 20,000. In this transaction Chair, President & CEO of this company bought 100,000 shares at a rate of $0.20, taking the stock ownership to the 613,252 shares.
Aptose Biosciences Inc (APTO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.39% per share during the next fiscal year.
Aptose Biosciences Inc (NASDAQ: APTO) Trading Performance Indicators
Check out the current performance indicators for Aptose Biosciences Inc (APTO). In the past quarter, the stock posted a quick ratio of 1.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.05, a number that is poised to hit -0.35 in the next quarter
Technical Analysis of Aptose Biosciences Inc (APTO)
Analysing the last 5-days average volume posted by the [Aptose Biosciences Inc, APTO], we can find that recorded value of 0.51 million was lower than the volume posted last year of 0.79 million. As of the previous 9 days, the stock’s Stochastic %D was 31.27%. Additionally, its Average True Range was 0.02.
During the past 100 days, Aptose Biosciences Inc’s (APTO) raw stochastic average was set at 20.93%, which indicates a significant increase from 17.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.27% in the past 14 days, which was lower than the 113.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2254, while its 200-day Moving Average is $0.5757. Now, the first resistance to watch is $0.2015. This is followed by the second major resistance level at $0.2111. The third major resistance level sits at $0.2203. If the price goes on to break the first support level at $0.1827, it is likely to go to the next support level at $0.1735. Now, if the price goes above the second support level, the third support stands at $0.1639.
Aptose Biosciences Inc (NASDAQ: APTO) Key Stats
There are currently 60,181K shares outstanding in the company with a market cap of 11.54 million. Presently, the company’s annual sales total 0 K according to its annual income of -51,210 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,950 K.
